CKR-10 Antibody (E-2): sc-365957. Western blot analysis of CKR-10 expression in MCF7 (A), SJRH30 (B), TK-1 (C), C2C12 (D) and C6 (E) whole cell lysates.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
CKR-10 Antibody (E-2): sc-365957. Western blot analysis of CKR-10 expression in MCF7 (A), SJRH30 (B), TK-1 (C), C2C12 (D) and C6 (E) whole cell lysates.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
CKR-10 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the CKR-10 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: CKR-10 Antibody (E-2): sc-365957